From Times of Israel:
Pioneering scientist Michal Schwartz of the Weizmann Institute says that she and her team of researchers are close to developing a groundbreaking immunotherapy treatment that could help boost the immune system — and slow the aging process.The research appeared in the peer-reviewed journal Neuron.Schwartz, a 2023 Israel Prize recipient, was the first to discover that the brain is highly dependent on the immune system for its lifelong maintenance and function. She has spent the last 27 years studying the connection between the immune system and the aging brain.Her international team of researchers now believes that an intervention to boost the immune system could potentially slow or even halt the aging of the brain as well as the body.
Founded in 2024 by CEO Benjamini and Dr. Adi Naor Pomerantz, FireDome is developing a wildfire defense system, modeled after the Iron Dome, that pairs defense tactics and AI technology. Designed to detect and suppress fires, the autonomous patent-pending system is geared to provide two layers of protection.In response to an alert by the fire department that a wildfire is approaching an area, first, a mechanical stationary launcher releases capsules similar to projectiles that open before impact to disperse eco-friendly fire-retardant to create a protective barrier and block the path of encroaching wildfires. Second, an AI-powered system leveraging computer vision and sensor technology detects and extinguishes spot fires caused by airborne embers that bypass the primary barrier.
Israeli company CorNeat Vision has developed an artificial cornea that could help address the global shortage of cornea donors. Currently, there's only one donor cornea available for every 70 needed, with about two million new cases of corneal blindness reported each year.The key innovation is their CorNeat KPro, which uses a special synthetic nano-fabric that mimics the eye's natural tissue structure. Unlike previous artificial corneas, this one doesn't require any donor tissue and can be implanted through a relatively simple 45-minute surgery. The device simply snaps into place and is sutured to the eye.What makes this particularly promising is:
- Patients can see normally right after the surgery
- It heals faster than alternatives because it integrates with the conjunctiva (the white part of the eye), which heals better than the cornea
- It allows doctors to perform future eye procedures if needed without removing the device
- The artificial material is designed to be long-lasting and won't degrade over time
The company is planning clinical trials in several countries, including Israel, Canada, the Netherlands, and France.This development could provide hope for millions of people suffering from corneal blindness who currently face long waiting times for donor corneas.
One clinical paper I found said that the first patient in 2022 achieved to 20/320 vision, which is legally blind in many contexts but is a great deal better than total corneal blindness. I imagine things are improving now.
|
"He's an Anti-Zionist Too!" cartoon book (December 2024) PROTOCOLS: Exposing Modern Antisemitism (February 2022) |
 |
Buy